S. Dimova et T. Stoytchev, INFLUENCE OF RIFAMPICIN ON THE TOXICITY AND THE ANALGESIC EFFECT OF ACETAMINOPHEN, European journal of drug metabolism and pharmacokinetics, 19(4), 1994, pp. 311-317
The influence of rifampicin on the toxicity, analgesic effect and phar
macokinetics of acetaminophen was studied in male albino mice. Repeate
d administration of rifampicin (50 mg/kg i.p. daily for 6 days) shorte
ned hexobarbital sleeping time and increased liver weight, microsomal
cytochrome P-450 and heme contents, NADPH-cytochrome c reductase and e
thylmorphine-N-demethylase activities. Aniline hydroxylase activity wa
s decreased and glucuronidation of p-nitrophenol was unaffected. Rifam
picin pretreatment changed neither the LD(50) of acetaminophen nor the
hepatic glutathione level nor the glutathione depletion provoked by t
he toxic dose of acetaminophen (737 mg/kg p.o.). This suggests that ri
fampicin has no influence on the amount of acetaminophen toxic metabol
ites formed in the liver. Rifampicin decreased the acetaminophen analg
esic effect in mice. Rifampicin decreased the C-max, the half-time, th
e MRT and the AUC of acetaminophen and accelerated its clearance. The
plasma concentration of acetaminophen glucuronide and acetaminophen su
lfate was increased. It is assumed that the most probable mechanism by
which rifampicin decreases acetaminophen analgesia is the accelerated
acetaminophen elimination.